Literature DB >> 19264651

Influenza A virus proteins PB1 and NS1 are subject to functionally important phosphorylation by protein kinase C.

Shohreh Mahmoudian1, Sabrina Auerochs1, Monika Gröne1, Manfred Marschall1.   

Abstract

The virulence of influenza A viruses depends on the activity of the viral RNA polymerase complex and viral regulatory phosphoproteins. We identified that the protein kinase C (PKC) inhibitor Gö6976 had a post-entry anti-influenza viral effect, by using a polymerase activity-based reporter assay. This inhibitory effect was observed for influenza virus-infected cells as well as for cells transiently transfected with constructs for the RNA polymerase complex. Importantly, the in vitro analysis of viral protein phosphorylation identified PKCalpha as a kinase phosphorylating PB1 and NS1, but not PB2, PA or NP. Gö6976 was able to block PKC-specific phosphorylation in vitro. Thus, our data suggest that PKC contributes to the phosphorylation of influenza PB1 and NS1 proteins which appears to be functionally relevant for both viral RNA polymerase activity and efficient viral replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264651     DOI: 10.1099/vir.0.009050-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.

Authors:  Corina Hutterer; Jan Eickhoff; Jens Milbradt; Klaus Korn; Isabel Zeitträger; Hanife Bahsi; Sabrina Wagner; Gunther Zischinsky; Alexander Wolf; Carsten Degenhart; Anke Unger; Matthias Baumann; Bert Klebl; Manfred Marschall
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

2.  In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses.

Authors:  Manfred Marschall; Thomas Stamminger; Andreas Urban; Steffen Wildum; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

3.  Tyrosine 132 phosphorylation of influenza A virus M1 protein is crucial for virus replication by controlling the nuclear import of M1.

Authors:  Shanshan Wang; Zhendong Zhao; Yuhai Bi; Lei Sun; Xiaoling Liu; Wenjun Liu
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

4.  Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus.

Authors:  Judith G Alamares-Sapuay; Luis Martinez-Gil; Silke Stertz; Matthew S Miller; Megan L Shaw; Peter Palese
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

5.  SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization.

Authors:  Andres Santos; Sangita Pal; Jason Chacón; Katherine Meraz; Jeanette Gonzalez; Karla Prieto; Germán Rosas-Acosta
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

6.  Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs.

Authors:  Sangita Pal; Juan M Rosas; Germán Rosas-Acosta
Journal:  J Virol Methods       Date:  2009-11-14       Impact factor: 2.014

7.  Interactome analysis of the influenza A virus transcription/replication machinery identifies protein phosphatase 6 as a cellular factor required for efficient virus replication.

Authors:  Ashley York; Edward C Hutchinson; Ervin Fodor
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

8.  Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry.

Authors:  Edward C Hutchinson; Eleanor M Denham; Benjamin Thomas; David C Trudgian; Svenja S Hester; Gabriela Ridlova; Ashley York; Lauren Turrell; Ervin Fodor
Journal:  PLoS Pathog       Date:  2012-11-08       Impact factor: 6.823

9.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

10.  A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.

Authors:  Mila Brum Ortigoza; Oliver Dibben; Jad Maamary; Luis Martinez-Gil; Victor H Leyva-Grado; Pablo Abreu; Juan Ayllon; Peter Palese; Megan L Shaw
Journal:  PLoS Pathog       Date:  2012-04-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.